These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 17290591)

  • 1. Twenty years of contributions to the study and prevention of uterine cancer.
    Garrido Martínez JL; Díaz MM; Villarreal A
    Eur J Gynaecol Oncol; 2006; 27(6):600-2. PubMed ID: 17290591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative findings of oncogenic cervical risk and its follow-up in two different periods 1982-1999 and 2000-2007.
    Garrido MJ
    Eur J Gynaecol Oncol; 2010; 31(5):559-61. PubMed ID: 21061800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and epidemiological correlations between the infection with HPV 16 and HPV 18 and female cervical lesions.
    Stoian M; Repanovici R; Corniţescu F
    Rom J Virol; 1995; 46(3-4):161-70. PubMed ID: 9179967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical cytohistologic correlations of lesions of the female genital tract: our experience in Panama.
    Garrido Martínez JL; Díaz MM; Villarreal A
    Eur J Gynaecol Oncol; 2007; 28(3):217-9. PubMed ID: 17624091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for genital papillomavirus infection in populations at high and low risk for cervical cancer.
    Reeves WC; Gary HE; Johnson PR; Icenogle JP; Brenes MM; de Britton RM; Dobbins JG; Schmid DS
    J Infect Dis; 1994 Oct; 170(4):753-8. PubMed ID: 7930714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Routine cervical screening by primary HPV testing: early findings in the renewed National Cervical Screening Program.
    Machalek DA; Roberts JM; Garland SM; Thurloe J; Richards A; Chambers I; Sivertsen T; Farnsworth A
    Med J Aust; 2019 Aug; 211(3):113-119. PubMed ID: 31168828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Human papillomavirus typing in routine cervical smears. Results from a series of 3778 patients].
    Levert M; Clavel C; Graesslin O; Masure M; Birembaut P; Quereux C; Gabriel R
    Gynecol Obstet Fertil; 2000 Oct; 28(10):722-8. PubMed ID: 11244634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural history and epidemiology of HPV infection and cervical cancer.
    Castellsagué X
    Gynecol Oncol; 2008 Sep; 110(3 Suppl 2):S4-7. PubMed ID: 18760711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [HPV infection in etiology of uterine cervix cancer].
    Olejek A
    Ginekol Pol; 2008 Feb; 79(2):126-32. PubMed ID: 18510092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncological risk, evaluation 1982-1989, Panama.
    Garrido JL
    Eur J Gynaecol Oncol; 1993; 14(1):68-70. PubMed ID: 8386084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Verrucous carcinoma of the cervix: detection of carcinogenetic human papillomavirus types and their role during follow-up.
    Frega A; Lukic A; Nobili F; Palazzo A; Iacovelli R; French D; Moscarini M
    Anticancer Res; 2007; 27(6C):4491-4. PubMed ID: 18214065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus frequency of women at low risk of developing cervical cancer: a preliminary study from a Turkish university hospital.
    Ozçelik B; Serin IS; Gökahmetoğlu S; Başbuğ M; Erez R
    Eur J Gynaecol Oncol; 2003; 24(2):157-9. PubMed ID: 12701968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical follow-up of women infected with human papillomavirus-16, either alone or with other human papillomavirus types: identification of different risk groups.
    Cottier O; Sahli R; Mihaescu A; De Grandi P; Boulvain M; Gerber S
    Am J Obstet Gynecol; 2009 Mar; 200(3):286.e1-6. PubMed ID: 19167699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus infection and cervical cancer in Brazil: a retrospective study.
    Cavalcanti SM; Deus FC; Zardo LG; Frugulhetti IC; Oliveira LH
    Mem Inst Oswaldo Cruz; 1996; 91(4):433-40. PubMed ID: 9070405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Screening and vaccination: two synergic tools for the prevention of cervical cancer].
    Zaratti L; Senatore S; Franco E
    Ig Sanita Pubbl; 2007; 63(4):449-57. PubMed ID: 17912281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Markowitz LE; Dunne EF; Saraiya M; Lawson HW; Chesson H; Unger ER; ;
    MMWR Recomm Rep; 2007 Mar; 56(RR-2):1-24. PubMed ID: 17380109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervical cytology and colposcopy in young patients attending genitourinary medicine clinics: invalid intrusion or preventive opportunity and definitive audit?
    Moss TR
    Cytopathology; 1999 Feb; 10(1):2-7. PubMed ID: 10068881
    [No Abstract]   [Full Text] [Related]  

  • 18. [Frequency of HPV infection of the uterine cervix among perimenopausal women in Wielkopolska Region].
    Zietkowiak W; Zimna K; Sroka Ł; Uchman P; Sajdak S
    Ginekol Pol; 2002 Nov; 73(11):939-44. PubMed ID: 12722378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines.
    Monsonego J; Zerat L; Syrjänen K; Zerat JC; Smith JS; Halfon P
    Vaccine; 2012 Jul; 30(35):5215-21. PubMed ID: 22713720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Papillomavirus-Related Cancers.
    Li Y; Xu C
    Adv Exp Med Biol; 2017; 1018():23-34. PubMed ID: 29052130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.